Biological activity of Asp-hemolysin as a regulation factor to atherogenic effect by oxidized low-density lipoprotein

Yakugaku Zasshi

Volumn 126, Issue 10, 2006, Pages 955-964

  Kumagai, Takeshi ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Asp hemolysin; Asp hemolysin related peptide; Binding; Expression; Factor VIII; Oxidized low density lipoprotein

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; HEMOLYSIN; HYBRID PROTEIN; MALTOSE BINDING PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PEPTIDE; PEPTIDE HEMOLYSIN RELATED PEPTIDE 21; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ATHEROGENESIS; BLOOD CLOTTING; CELL PROLIFERATION; CONCENTRATION RESPONSE; ESCHERICHIA COLI; IMMUNOCOMPETENT CELL; MACROPHAGE; PARTIAL THROMBOPLASTIN TIME; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PURIFICATION; REGULATORY MECHANISM; REVIEW; STRUCTURE ACTIVITY RELATION;

ASPERGILLUS FUMIGATUS; ATHEROSCLEROSIS; BLOOD COAGULATION; FACTOR VIII; FUNGAL PROTEINS; HEMOLYSIN PROTEINS; HUMANS; LIPOPROTEINS, LDL; METABOLIC DETOXICATION, DRUG; PROTEIN BINDING;

EID: 33749383940     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.126.955     Document Type: Review

References (28)

1. Yokota K., Shimada H., Kamaguchi A., Sakaguchi O., Microbiol. Immunol., 21, 11-22 (1977).
2. Ebina K., Sakagami H., Yokota K., Kondo H., Biochim. Biophys. Acta, 1219, 148-150 (1994).
3. Fukuchi Y., Kumagai T., Ebina K., Yokota K., Biol. Pharm. Bull., 19, 547-550 (1996).
4. Fukuchi Y., Kudo Y., Kumagai T., Ebina K., Yokota K., Biol. Pharm. Bull., 19, 1380-1381 (1996).
5. Kudo Y., Fukuchi Y., Kumagai T., Ebina K., Yokota K., Biochim. Biophys. Acta, 1568, 183-188 (2001).
6. Kudo Y., Ootani T., Kumagai T., Fukuchi Y., Ebina K., Yokota K., Biol. Pharm. Bull., 25, 787-790 (2002).
7. Wiztum J. L., Steinberg D., J. Clin. Invest., 88, 1785-1792 (1991).
8. Ross R., N. Engl. J. Med., 340, 115-126 (1999).
9. Luis A. J., Nature, 407, 233-241 (2000).
10. Li A. C., Glass C. K., Nat. Med., 8, 1235-1242 (2002).
11. Fan J., Watanabe T., J. Atheroscler. Thromb., 10, 63-71 (2003).
12. Curtis C. G., Brown K. L., Credo R. B., Domanik R. A., Gray A., Steinberg P., Lorand L., Biochemistry, 13, 3774-3780 (1974).
13. Holvoet P., Collen D., Curr. Opin. Lipidol., 8, 320-328 (1997).
14. Kumagai T., Hoshi Y., Tsutsumi H., Ebina K., Yokota K., Biol. Pharm. Bull., 28, 952-956 (2005).
15. Itabe H., Prog. Lipid Res., 37, 181-207 (1998).
16. Steinbrecher U. P., Pritchard P. H., J. Lipid Res., 30, 305-315 (1989).
17. Liapikos T. A., Antonopoulou S., Karabina S. P., Tsoukatos D. C., Demopoulos C. A., Tselepis A. D., Biochim. Biophys. Acta, 1212, 353-360 (1994).
18. Denton C., Tselepis A. D., Chapman M. J., Ninio E., Biochim. Biophys. Acta, 1299, 353-357 (1996).
19. Kumagai T., Kudo Y., Fukuchi Y., Ebina K., Yokota K., Biol. Pharm. Bull., 25, 115-117 (2002).
20. Moreno P. R., Falk E., Palacios I. F., Newell J. B., Fuster V., Fallon J. T., Circulation, 90, 775-778 (1994).
21. Libby P., Circulation, 91, 2844-2850 (1995).
22. Moreno P. R., Bernardi V. H., Lopez-Cuellar J., Murcia A. M., Palacios I. F., Gold H. K., Mehran R., Sharma S. K., Nemerson Y., Fuster V., Fallon J. T., Circulation, 94, 3090-3097 (1996).
23. Matsumura T., Sakai M., Kobori S., Biwa T., Takemura T., Matsuda H., Hakamata H., Horiuchi S., Shichiri M., Arterioscler. Thromb. Vasc. Biol., 17, 3013-3020 (1997).
24. Martens J. S., Reiner N. E., Herrera-Velit P., Steinbrecher U. P., J. Biol. Chem., 273, 4915-4920 (1998).
25. Hamilton J. A., Myers D., Jessup W., Cochrane F., Byrne R., Whitty G., Moss S., Arterioscler. Thromb. Vasc. Biol., 19, 98-105 (1999).
26. Sakai M., Miyazaki A., Hakamata H., Sasaki T., Yui S., Yamazaki M., Shichiri M., Horiuchi S., J. Biol. Chem., 269, 31430-31435 (1994).
27. Kudo Y., Kumagai T., Fukuchi Y., Ebina K., Yokota K., Biol. Pharm. Bull., 22, 549-550 (1999).
28. Kumagai T., Ogawa N., Tsutsumi H., Ebina K., Yokota K., Biol. Pharm. Bull., 28, 1381-1384 (2005).